跳至主要内容
临床试验/ISRCTN15858091
ISRCTN15858091已完成不适用

A randomised, controlled trial of interpersonal psychotherapy (IPT) and citalopram for depression in coronary artery disease

Montreal Heart Institute Research Center (Canada)0 个研究点目标入组 280 人开始时间: 2005年8月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Persons of either sex in age groups: 18 years and above.
  • 1. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnosis of current major depressive episode based on the Structured Clinical Interview for Depression (SCID) with at least 4 weeks duration
  • 2. Baseline score greater than 19 on the centralized, telephone-administered 24-item, Hamilton Depression Rating Scale (HAM-D)
  • 3. Evidence of coronary artery disease (CAD) based on hospital chart evidence of a previous hospitalization for acute myocardial infarction, or coronary angiographic evidence of greater than 50% blockage in at least one major coronary artery, or prior revascularization
  • 4. Stable CAD based on physician?s clinical judgement
  • 5. Provision of informed consent

排除标准

  • 1. Less than 18 years of age
  • 2. Coronary bypass surgery planned during the next 4 months
  • 3. Canadian Cardiovascular Society Angina Class (CCS) = 4
  • 4. SCID documented bipolar disorder, major depression with psychotic features or evidence of substance abuse or dependency during the previous 12 months
  • 5. Serious suicide or risk based on clinical judgment
  • 6. Use of anti-depressants, lithium or anti-convulsants for mood disorder
  • 7. Currently undergoing any form of psychotherapy
  • 8. Absence of response to a previous adequate trial of citalopram or IPT
  • 9. Two previous unsuccessful trials of treatment for depression for the index episode
  • 10. Lifetime history of early termination (less than 8 weeks) of citalopram because of adverse events or side-effects
  • 11. Lifetime history of early termination (less than 8 weeks) of two other selective serotonin reuptake inhibitor (SSRI) antidepressants (paroxetine, fluoxetine, fluvoxamine, sertraline) because of adverse events or side-effects
  • 12. Significant cognitive problems (Mini-Mental Status Exam [MMSE] less than 24)
  • 13. Depression due to a general medical condition based on clinical judgment
  • 14. Participation in other trials
  • 15. Inability to speak French or English
  • 16. Investigator?s judgment that a patient is unable or unwilling to comply with the study regimen

研究者

发起方
Montreal Heart Institute Research Center (Canada)

相似试验